← Eichor
Study identifier: NCT07636720 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Sensing in Sleep Deep Brain Stimulation

Condition: Parkinson's Disease and Parkinsonism · Dyssomnia  ·  Sponsor: The University of Texas Health Science Center at San Antonio

PhaseNA
Planned participants20
Who can joinAll sexes, 40 Years to 80 Years
Healthy volunteersNo

About this study

Participants in this study have Parkinson's Disease and already have a device, called the Percept RC Deep Brain Stimulation device implanted. People with Parkinson's disease often have issues related to sleep such as bad quality of sleep, waking up often and sleep apnea (breathing stops and starts during sleep). For this study, participants will be sleeping overnight in the study sleep lab for two nights. One night, Deep Brain Stimulation (DBS) device turned on and one night with the DBS off, either in this order or the reverse.

This description comes directly from the study's public registry record.

Talk to the study team

Eleni O Vaou, MD  ·  210 450 8048  ·  vaou@uthscsa.edu

Omalys Biggs Rodriguez  ·  210-450-7547  ·  biggsrodrigu@uthscsa.edu

Always discuss trial participation with your own doctor first.

Locations (1)

The University of Texas Health Science Center at San Antonio - Brain Health CenterSan Antonio, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07636720